CD40 in coronary artery disease: a matter of macrophages?

被引:0
|
作者
Matthijs F. Jansen
Maurits R. Hollander
Niels van Royen
Anton J. Horrevoets
Esther Lutgens
机构
[1] VU University Medical Centre,Department of Molecular Cell Biology and Immunology
[2] Academic Medical Centre,Department of Medical Biochemistry
[3] VU University Medical Center,Department of Cardiology
[4] Ludwig Maximilians University,Institute for Cardiovascular Prevention (IPEK)
来源
关键词
CD40; Macrophage; Atherosclerosis; Arteriogenesis; Neointima formation; Ischemic heart disease;
D O I
暂无
中图分类号
学科分类号
摘要
Coronary artery disease (CAD), also known as ischemic heart disease (IHD), is the leading cause of mortality in the western world, with developing countries showing a similar trend. With the increased understanding of the role of the immune system and inflammation in coronary artery disease, it was shown that macrophages play a major role in this disease. Costimulatory molecules are important regulators of inflammation, and especially, the CD40L-CD40 axis is of importance in the pathogenesis of cardiovascular disease. Although it was shown that CD40 can mediate macrophage function, its exact role in macrophage biology has not gained much attention in cardiovascular disease. Therefore, the goal of this review is to give an overview on the role of macrophage-specific CD40 in cardiovascular disease, with a focus on coronary artery disease. We will discuss the function of CD40 on the macrophage and its (proposed) role in the reduction of atherosclerosis, the reduction of neointima formation, and the stimulation of arteriogenesis.
引用
收藏
相关论文
共 50 条
  • [1] CD40 in coronary artery disease: a matter of macrophages?
    Jansen, Matthijs F.
    Hollander, Maurits R.
    van Royen, Niels
    Horrevoets, Anton J.
    Lutgens, Esther
    [J]. BASIC RESEARCH IN CARDIOLOGY, 2016, 111 (04)
  • [2] The Relation between CD40 Ligand and Coronary Artery Disease
    Balta, Sevket
    Ozturk, Cengiz
    [J]. CARDIOLOGY, 2015, 131 (02) : 107 - 108
  • [3] Pentoxifylline decreases soluble CD40 ligand concentration and CD40 gene expression in coronary artery disease patients
    Shamsara, Jamal
    Mohammadpour, Amir Hooshang
    Behravan, Javad
    Falsoleiman, Homa
    Ramezani, Mohammad
    [J]. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2012, 34 (03) : 523 - 529
  • [4] Is soluble CD40 ligand a mediator of angiogenesis in patients with coronary artery disease?
    Lim, Hoong Sern
    Tayebjee, Muzahir H.
    Tan, Kiat T.
    Patel, Jeetesh V.
    MacFadyen, Robert J.
    Lip, Gregory Y. H.
    [J]. THROMBOSIS RESEARCH, 2008, 122 (03) : 307 - 313
  • [5] Clopidogrel decreases soluble CD40 ligand in patients with stable coronary artery disease
    Azar, RR
    Kassab, R
    Zoghbi, A
    Aboujaoude, S
    Ghorra, P
    El-Osta, H
    Germanos, M
    Salame, E
    [J]. CIRCULATION, 2005, 112 (17) : U544 - U544
  • [6] CD40 ligand increases expression of its receptor CD40 in human coronary artery endothelial cells
    Chai, Hong
    Yan, Shaoyu
    Wang, Han
    Zhang, Rongxin
    Lin, Peter H.
    Yao, Qizhi
    Chen, Changyi
    [J]. SURGERY, 2006, 140 (02) : 236 - 242
  • [7] Analysis of CD154 and CD40 expression in native coronary atherosclerosis and transplant associated coronary artery disease
    Szabolcs, MJ
    Cannon, PJ
    Thienel, U
    Chen, RZ
    Michler, RE
    Chess, L
    Yellin, MJ
    [J]. VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 2000, 437 (02): : 149 - 159
  • [8] Analysis of CD154 and CD40 expression in native coronary atherosclerosis and transplant associated coronary artery disease
    Matthias J. Szabolcs
    Paul J. Cannon
    Ulrich Thienel
    Rongzhen Chen
    Robert E. Michler
    Leonard Chess
    M. J. Yellin
    [J]. Virchows Archiv, 2000, 437 : 149 - 159
  • [9] Soluble CD40 ligand and outcome in patients with coronary artery disease undergoing percutaneous coronary intervention
    Angeli, Fabio
    Verdecchia, Paolo
    Savonitto, Stefano
    Cavallini, Sara
    Santucci, Andrea
    Coiro, Stefano
    Sclafani, Rocco
    Riccini, Clara
    De Servi, Stefano
    Cavallini, Claudio
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2022, 60 (01) : 118 - 126
  • [10] CD40: A new marker in coronary heart disease
    Blaton, V.
    [J]. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2007, 67 (02): : 113 - 113